These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study. Park SI; Horwitz SM; Foss FM; Pinter-Brown LC; Carson KR; Rosen ST; Pro B; Hsi ED; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Shustov AR; Cancer; 2019 May; 125(9):1507-1517. PubMed ID: 30694529 [TBL] [Abstract][Full Text] [Related]
5. Frequency, distribution, and immunomorphologic characteristics of peripheral T-cell lymphoma, not otherwise specified in a tertiary care center in Southern India. Lakshmanan A; Sikri D; Patil S; Kurian A; Annapurneswari S; Nair S Indian J Pathol Microbiol; 2018; 61(2):204-208. PubMed ID: 29676358 [TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma. Mohammed Saleh MF; Kotb A; Abdallah GEM; Muhsen IN; El Fakih R; Aljurf M Curr Oncol; 2021 Dec; 28(6):5480-5498. PubMed ID: 34940095 [TBL] [Abstract][Full Text] [Related]
7. Strategies for aggressive T-cell lymphoma: divide and conquer. Pinter-Brown LC Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):154-159. PubMed ID: 33275729 [TBL] [Abstract][Full Text] [Related]
8. The aggressive peripheral T-cell lymphomas: 2017. Armitage JO Am J Hematol; 2017 Jul; 92(7):706-715. PubMed ID: 28516671 [TBL] [Abstract][Full Text] [Related]
9. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma. Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H; Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159 [TBL] [Abstract][Full Text] [Related]
10. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Iqbal J; Weisenburger DD; Greiner TC; Vose JM; McKeithan T; Kucuk C; Geng H; Deffenbacher K; Smith L; Dybkaer K; Nakamura S; Seto M; Delabie J; Berger F; Loong F; Au WY; Ko YH; Sng I; Armitage JO; Chan WC; Blood; 2010 Feb; 115(5):1026-36. PubMed ID: 19965671 [TBL] [Abstract][Full Text] [Related]
11. Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States. Hsi ED; Horwitz SM; Carson KR; Pinter-Brown LC; Rosen ST; Pro B; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Collie AM; Gruver AM; Grzywacz BJ; Turakhia S; Shustov AR; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Park SI; Foss FM Clin Lymphoma Myeloma Leuk; 2017 Apr; 17(4):193-200. PubMed ID: 28209473 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Study of 30 Cases of Peripheral T-cell Lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan. Eladl AE; Satou A; Elsayed AA; Suzuki Y; Kato S; Asano N; Nakamura S Am J Surg Pathol; 2017 Apr; 41(4):506-516. PubMed ID: 28125450 [TBL] [Abstract][Full Text] [Related]
13. How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future. Schmitz N; de Leval L Br J Haematol; 2017 Mar; 176(6):851-866. PubMed ID: 27982416 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of angioimmunoblastic T-cell lymphoma]. Tobinai K Nihon Rinsho; 2012 Apr; 70 Suppl 2():525-30. PubMed ID: 23134010 [No Abstract] [Full Text] [Related]
15. Peripheral T cell lymphoma: Clinico-pathological characteristics & outcome from a tertiary care centre in south India. Nemani S; Korula A; Agrawal B; Kavitha ML; Manipadam MT; Sigamani E; George B; Srivastava A; Viswabandya A; Mathews V Indian J Med Res; 2018 May; 147(5):464-470. PubMed ID: 30082570 [TBL] [Abstract][Full Text] [Related]
16. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760 [TBL] [Abstract][Full Text] [Related]
18. T-cell Lymphomas: Updates in Biology and Diagnosis. Ondrejka SL; Hsi ED Surg Pathol Clin; 2016 Mar; 9(1):131-41. PubMed ID: 26940273 [TBL] [Abstract][Full Text] [Related]
19. Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network. Herrera AF; Crosby-Thompson A; Friedberg JW; Abel GA; Czuczman MS; Gordon LI; Kaminski MS; Millenson MM; Nademanee AP; Niland JC; Rodig SJ; Rodriguez MA; Zelenetz AD; LaCasce AS Cancer; 2014 Jul; 120(13):1993-9. PubMed ID: 24706502 [TBL] [Abstract][Full Text] [Related]